2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $71B | $76B | $80B | $82B | $84B |
Cost of Revenue | $35B | $37B | $42B | $43B | $41B |
Gross Profit | $36B | $39B | $38B | $39B | $43B |
Gross Profit % | 50% | 51% | 47% | 48% | 51% |
R&D Expenses | $0 | $0 | $0 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $13B | $14B | $15B | $15B | $15B |
Dep. & Amort. | $3B | $2.7B | $2.8B | $2.7B | $2.9B |
Def. Tax | -$596M | -$258M | -$402M | -$453M | -$244M |
Stock Comp. | $558M | $540M | $528M | $545M | $562M |
Chg. in WC | $1.2B | $371M | -$1.1B | -$1.2B | -$436M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $16B | $10B | $7.2B | $8.2B | $9.5B |
ST Investments | $0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $16B | $10B | $7.2B | $8.2B | $9.5B |
Receivables | $4.2B | $4.7B | $5.1B | $5.5B | $6.1B |
Inventory | $5.5B | $6B | $6.9B | $7.1B | $7B |
Q3 organic sales grew 1%, with 7 of 10 product categories holding or growing sales; earnings per share were $1.54, up 1% year-over-year, and core EPS increased 3% on a currency-neutral basis.
Consumer and retailer volatility, especially in the US and Europe, led to lower consumption and inventory reductions; however, P&G maintained or grew market share in most categories and regions, with private label shares trending down.
P&G is doubling down on its integrated growth strategy, focusing on innovation across all value tiers, productivity improvements, and maintaining strong investment in brand superiority despite near-term market softness.
Fiscal 2025 guidance: organic sales growth expected at approximately 2% (Q4 range: 0.5% to 4.5%), core EPS forecasted at $6.72 to $6.82 (2% to 4% growth), with $10B in dividends and $6B–$7B in share repurchases planned.
Tariff impacts are estimated at $1B–$1.5B pre-tax (about 3% of COGS), with mitigation planned through productivity, sourcing changes, and selective pricing; commodity cost headwind remains at $200M (excluding tariffs).